Navigation Links
Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies
Date:3/12/2013

NEWCASTLE-UPON-TYNE, England, March 12, 2013 /PRNewswire/ --

  • Leica Biosystems and Synthon Biopharmaceuticals announce partnership to develop a companion diagnostic test for solid tumors
  • Leica Biosystems will develop a fully automated tissue-based companion diagnostic test to run on the BOND™ automated advanced staining systems
  • Synthon strengthens its innovative drug pipeline with the development of a companion diagnostic test
  • This agreement provides framework for further collaboration projects

Leica Biosystems and Synthon Biopharmaceuticals, a subsidiary of specialty pharma company Synthon, today announced an agreement to collaborate on the development and commercialization of a companion diagnostic test using the Leica BOND system, paired with one of Synthon Biopharmaceutical's antibody-drug conjugates (ADCs), to enhance the treatment of solid tumors.

"We are pleased to be working with Synthon Biopharmaceuticals on cancer therapies with the Leica BOND platform," added Matthias Weber , President of Leica Biosystems, MD.  "This partnership with Synthon is the next example of our commitment to provide unique tests to support the management of cancer patients. The ease of use and high staining quality of our BOND systems makes them ideal platforms on which to deploy these very informative tests."

Dr. Leon Hooftman , Chief Medical Officer at Synthon, comments: "Synthon is committed to develop a best-in-class ADC. This collaboration with Leica Biosystems will support us in delivering on that ambition."

About Leica Biosystems

Leica Biosystems is a global leader in workflow solutions and automation, striving to advance cancer diagnostics to improve patients' lives. Leica Biosystems provides anatomical pathology laboratories and researchers a comprehensive product range for each step in the pathology process, from sample preparation and staining to imaging and reporting. Leica's work program will be led from their new Companion Diagnostics Research and Development site in Danvers, Greater Boston, Massachusetts, with kit manufacturing occurring in Newcastle. Leica's easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. The company is represented in over 100 countries. It has manufacturing facilities in 6 countries, sales and service organizations in 19 countries, and an international network of dealers. The company is headquartered in Nussloch, Germany. Further information can be found at http://www.LeicaBiosystems.com

About Synthon

Synthon, with headquarters in Nijmegen, the Netherlands is an international pharmaceutical company and a leader in the field of generic medicines. Synthon has been working in biotechnology since 2007 and is developing rapidly into a specialty pharmaceutical company, focusing on the therapeutic areas of auto-immune diseases - particularly multiple sclerosis - and oncology. Our products are currently approved by regulatory agencies in over 80 countries worldwide and marketed through strategic partnerships and - in dedicated areas - through direct sales. Synthon employs about 1,400 staff worldwide, and in 2011 it recorded a turnover of EUR 260 million. For more information, go to http://www.synthon.com.  

http://www.LeicaBiosystems.com

 



'/>"/>
SOURCE Leica Biosystems
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Indigo Biosystems Among “Best Places to Work” in Indiana
2. Indigo Biosystems Nominated for Two TechPoint Mira Awards for Technology Excellence and Innovation
3. Genesis Biosystems Unveils Innovative Skin Treatment at Esthétique SPA International Trade Show
4. Lucas Bagnell Varga LLC Secures $17.4 Million Award For Former Applied Biosystems Executives
5. Aushon BioSystems and AH diagnostics unterzeichnen Distributionsvertrag für Skandinavien
6. Aushon BioSystems and AH diagnostics Sign Distribution Deal for Scandinavia
7. AyoxxA Biosystems Closes Series A Financing Round
8. Aushon BioSystems Appoints Martin Verhoef Chief Executive Officer
9. Ahram Biosystems Announces Launch of the New Economy Model F1-12 of Its Palm PCR Series
10. Keryx Biopharmaceuticals to Present at the 15th Annual BIO CEO & Investor Conference Presentation Scheduled for Monday, February 11th at 2:30 PM ET
11. Gallus BioPharmaceuticals Announces Appointment of Senior Baxter Executive as Chief Commercial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... Interpace Diagnostics Group, Inc. (NASDAQ: IDXG)("Interpace" ... useful molecular diagnostic tests and pathology services, today ... purchase agreement with three  institutional investors to purchase ... in a registered direct offering.  In a concurrent ... to the same investors warrants to purchase 855,000 ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... how current market conditions have influenced the most recent ... Regulus Therapeutics Inc. (NASDAQ: RGLS ), Abeona ... Inc. (NASDAQ: TBPH ), and Sage Therapeutics ... new research report by Grand View Research, global Biotech market size ...
(Date:1/19/2017)... PUNE, India , Jan. 19, 2017  Market Research Future ... The Global Market for Liquid Biopsy is growing rapidly and expected ... period. Market Highlights ... The Global Liquid Biopsy Market has been assessed as ... high growth figures and boom in the coming future. There has ...
(Date:1/19/2017)... ... January 19, 2017 , ... November Research Group, ... biopharmaceutical and medical device manufacturers and regulators, is proud to announce the worldwide ... email client designed to provide product vigilance departments with the flexibility and ease ...
Breaking Biology Technology:
(Date:1/11/2017)... , Jan. 11, 2017  Michael Johnson, co-founder of Visikol Inc. ... Group, Inc., has been named to the elite "Forbes 30 Under ... one of 600 people in 20 fields nationwide to be recognized ... the 15,000 applicants were selected. ... He is currently a PhD candidate at Rutgers University. ...
(Date:1/4/2017)... -- For the thousands of attendees at this year,s International Consumer Electronics Show ... biometric measurement devices and services, will be featuring its new line of ... Medical,s special CES Exhibit Suite , the new upper arm and ... WellnessConnected product platform.  Continue ... ...
(Date:12/22/2016)... SuperCom (NASDAQ:   SPCB ... e-Government, Public Safety, HealthCare, and Finance sectors announced today that Leaders ... to implement and deploy a community-based supportive services program to reduce ... , further expanding its presence in the state. ... This new program, which is expected ...
Breaking Biology News(10 mins):